Foliamin



Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 50.8%
Drug Use For Unknown Indication 13.1%
Meniere's Disease 4.5%
Osteoporosis 4.4%
Hypertension 4.2%
Product Used For Unknown Indication 2.7%
Conjunctivitis Allergic 2.3%
Juvenile Arthritis 2.3%
Prophylaxis 2.2%
Thrombosis Prophylaxis 2.0%
Gastritis Prophylaxis 1.8%
Epilepsy 1.7%
Gastritis 1.5%
Prophylaxis Against Gastrointestinal Ulcer 1.5%
Keratoconjunctivitis Sicca 1.0%
Antibiotic Prophylaxis 0.8%
Folate Deficiency 0.8%
Hyperuricaemia 0.8%
Anaemia 0.7%
Conjunctivitis 0.7%
Temporal Lobe Epilepsy 19.0%
Basal Cell Carcinoma 14.3%
Pneumocystis Jiroveci Pneumonia 11.1%
Nephrotic Syndrome 6.3%
Pyrexia 6.3%
Normal Newborn 4.8%
Upper Respiratory Tract Inflammation 4.8%
Uterine Cancer 4.8%
Oedema 3.2%
Platelet Count Decreased 3.2%
Prostatitis 3.2%
Retinal Haemorrhage 3.2%
Skin Ulcer 3.2%
White Blood Cell Count Decreased 3.2%
Colitis Ulcerative 1.6%
Delirium 1.6%
Glaucoma 1.6%
Herpes Zoster 1.6%
Hypercalcaemia 1.6%
Large Intestine Polyp 1.6%
Concomitant
Rheumatoid Arthritis 59.0%
Prophylaxis 12.8%
Osteoporosis 4.3%
Hypertension 3.4%
Product Used For Unknown Indication 2.6%
Gastritis 2.2%
Antibiotic Prophylaxis 2.1%
Drug Use For Unknown Indication 1.7%
Constipation 1.6%
Insomnia 1.6%
Juvenile Arthritis 1.3%
Diabetes Mellitus 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Folate Deficiency 0.9%
Gastric Ulcer 0.8%
Hyperlipidaemia 0.8%
Gastritis Prophylaxis 0.7%
Skin Ulcer 0.7%
Pleural Mesothelioma Malignant 0.7%
Juvenile Idiopathic Arthritis 0.6%
Pneumocystis Jiroveci Pneumonia 15.5%
Pneumonia 8.9%
Interstitial Lung Disease 8.5%
White Blood Cell Count Decreased 6.4%
Pyrexia 6.2%
Pulmonary Tuberculosis 5.8%
Vomiting 5.3%
Herpes Zoster 4.6%
Rheumatoid Arthritis 4.3%
Sepsis 4.2%
Urinary Tract Infection 3.9%
Lymphoma 3.4%
Breast Cancer 3.3%
Disseminated Tuberculosis 3.3%
Renal Impairment 3.3%
Hepatic Function Abnormal 2.8%
Rash 2.8%
Organising Pneumonia 2.5%
Renal Disorder 2.5%
Tuberculous Pleurisy 2.5%